Survivorship and Quality of Life in Head and Neck Cancer.
暂无分享,去创建一个
[1] M. King,et al. Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists’ perspectives , 2015, Quality of Life Research.
[2] D. Cella,et al. Outcomes toolbox for head and neck cancer research , 2015, Head & neck.
[3] Kevin C Oeffinger,et al. Causes of death in long‐term survivors of head and neck cancer , 2014, Cancer.
[4] J. Ringash. Facing head and neck cancer deaths head on: Lessons for survival , 2014, Cancer.
[5] J. Ringash,et al. Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review. , 2013, Oral oncology.
[6] D. Brachman,et al. The impact of concurrent granulocyte–macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial , 2014, Quality of Life Research.
[7] I. Barillot,et al. An international phase 3 trial in head and neck cancer: Quality of life and symptom results , 2014, Cancer.
[8] Jacques Ferlay,et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] G. Hordijk,et al. Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial , 2013, British Journal of Cancer.
[10] C. Ferreira,et al. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] M. Hier,et al. Head and neck cancer patients want us to support them psychologically in the posttreatment period: Survey results , 2013, Palliative and Supportive Care.
[12] K. Courneya,et al. Pilot, randomized trial of resistance exercise during radiation therapy for head and neck cancer , 2013, Head & neck.
[13] P. Aagaard,et al. Progressive resistance training rebuilds lean body mass in head and neck cancer patients after radiotherapy--results from the randomized DAHANCA 25B trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] T. Gupta,et al. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. , 2013, Oral oncology.
[15] M. Vidyasagar,et al. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy—a randomized controlled trial , 2013, Supportive Care in Cancer.
[16] M. Vidyasagar,et al. Effect of exercise training on functional capacity & quality of life in head & neck cancer patients receiving chemoradiotherapy , 2013, The Indian journal of medical research.
[17] S. Ristovski-Slijepcevic,et al. Cancer survivorship: why labels matter. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] D. Moher,et al. Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards , 2012, Quality of Life Research.
[19] D. Rietveld,et al. Five‐year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra‐arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer , 2012, Head & neck.
[20] C. Leles,et al. Effect of intraoral low‐level laser therapy on quality of life of patients with head and neck cancer undergoing radiotherapy , 2012, Head & neck.
[21] L. Johansson,et al. Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer — a randomized study , 2012, Head & neck.
[22] A. Bezjak,et al. Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers , 2011, Quality of Life Research.
[23] Eric J Feuer,et al. Projections of the cost of cancer care in the United States: 2010-2020. , 2011, Journal of the National Cancer Institute.
[24] A. Bottomley,et al. Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323) , 2010, British Journal of Cancer.
[25] H. Brenner,et al. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. , 2010, The oncologist.
[26] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[27] J. Dunn,et al. Predictors of change in unmet supportive care needs in cancer , 2010, Psycho-oncology.
[28] N. Scott,et al. EORTC Quality of Life Group translation procedure , 2009 .
[29] R. Martino,et al. Evaluation of quality of life and organ function in head and neck squamous cell carcinoma. , 2008, Hematology/oncology clinics of North America.
[30] A. Garden,et al. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. , 2008, International journal of radiation oncology, biology, physics.
[31] A. Chaturvedi,et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Gordon H Guyatt,et al. Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. , 2007, Mayo Clinic proceedings.
[33] D. Redelmeier,et al. Interpreting clinically significant changes in patient‐reported outcomes , 2007, Cancer.
[34] A. Garden,et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. , 2007, The Lancet. Oncology.
[35] K. Ang,et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] David J Weiss,et al. Psychometric Evaluation and Calibration of Health-Related Quality of Life Item Banks: Plans for the Patient-Reported Outcomes Measurement Information System (PROMIS) , 2007, Medical care.
[37] D. Goldstein,et al. Health‐related quality of life profiles based on survivorship status for head and neck cancer patients , 2007, Head & neck.
[38] J. Sham,et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. , 2006, International journal of radiation oncology, biology, physics.
[39] A. Garden,et al. Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] A. Bezjak,et al. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis , 2005, Head & neck.
[41] G. Lockwood,et al. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. , 2005, International journal of radiation oncology, biology, physics.
[42] R. Greil,et al. Normative data for functional assessment of cancer therapy General scale and its use for the interpretation of quality of life scores in cancer survivors , 2004, Acta oncologica.
[43] S. Straus,et al. Learning in practice The case for knowledge translation : shortening the journey from evidence to effect , 2003 .
[44] Robert L. White,et al. Phase III quality-of-life study results: impact on patients' quality of life to reducing xerostomia after radiotherapy for head-and-neck cancer--RTOG 97-09. , 2003, International journal of radiation oncology, biology, physics.
[45] G. Norman,et al. Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.
[46] S. Fosså,et al. Quality of life during radiotherapy for rectal cancer. , 2003, European journal of cancer.
[47] D. Patrick,et al. Assessing meaningful change in quality of life over time: a users' guide for clinicians. , 2002, Mayo Clinic proceedings.
[48] R. Biggar,et al. Changing patterns of tonsillar squamous cell carcinoma in the United States , 2000, Cancer Causes & Control.
[49] M. Sprangers,et al. Integrating response shift into health-related quality of life research: a theoretical model. , 1999, Social science & medicine.
[50] D. Osoba,et al. Completion rates in health-related quality-of-life assessment: approach of the National Cancer Institute of Canada Clinical Trials Group. , 1998, Statistics in medicine.
[51] G H Guyatt,et al. Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. , 1997, JAMA.
[52] J. Wright,et al. The minimal important difference: who's to say what is important? , 1996, Journal of clinical epidemiology.
[53] S. Franceschi,et al. Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[54] D L Sackett,et al. An assessment of clinically useful measures of the consequences of treatment. , 1988, The New England journal of medicine.
[55] D. Karnofsky,et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma , 1948 .
[56] Patricia A. Ganz,et al. From cancer patient to cancer survivor : lost in transition , 2006 .
[57] D. Osoba,et al. Analysis and interpretation of health-related quality-of-life data from clinical trials: basic approach of The National Cancer Institute of Canada Clinical Trials Group. , 2005, European journal of cancer.
[58] A. Bezjak,et al. Oncologists' use of quality of life information: Results of a survey of Eastern Cooperative Oncology Group physicians , 2004, Quality of Life Research.
[59] P. Schoemaker. The Expected Utility Model: Its Variants, Purposes, Evidence and Limitations , 1982 .